Global Wearable Wireless Sensor Market 2010–2014

This report forecasts the Global Wearable Wireless Sensors market to grow at a CAGR of 110% over the period 2010–2014. One of the key factors contributing to this market growth is the increase in number of chronically ill and aging population. The Global Wearable Wireless Sensors market has also been witnessing standardization of products. However, clinical and patient acceptance could pose a challenge to the growth of this market.

Wearable Wireless Sensor Market

Published: January 2012
No. of Pages: 31
Price: Single User License – US$1500              Corporate User License – US$2500




TechNavio’s report, the Global Wearable Wireless Sensors Market 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the sports and fitness, professional healthcare, and home healthcare landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Table of Contents
01. Executive Summary
02. Introduction
03. Market Coverage
04. Market Landscape
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and their Impact
09. Market Challenges
10. Market Trends
11. Key Vendor Analysis
11.1 Shimmer Research
11.2 BodyMedia Inc.
11.3 mc10 Inc.
12. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Wearable Wireless Sensors Market 2010–2014 (US$ million)
Exhibit 2: Global Wearable Wireless Sensors Market by Geographical Segmentation 2010
Exhibit 3: Global Wearable Wireless Sensors Market by Key Applications 2010
Exhibit 4: Global Wearable Wireless Sensors Market by Key Connectivity Technologies 2010
Exhibit 5: Global Wearable Wireless Sensors Market by Vendor Segmentation 2010

Read more info. about the report @ http://www.reportsnreports.com/reports/144911-global-wearable-wireless-sensor-market-2010-2014.html

Seed Treatment Market Trends and Global Forecasts (2011-2016)

This report estimates the market size of the global seed treatment market in terms of revenue. The market has been further segmented on the basis of crop types such as cereals and grains, oilseeds, and other crops as well as by sub-segmentation of insecticides, fungicides, and other chemical seed treatments such as plant growth regulators, micronutrients, etc. This segmentation is given for major regions and key countries in those regions. Market drivers, restraints and challenges, and crop trends are discussed in detail. Market share by participants for the overall market is discussed in detail in the report. We have also profiled leading players of this industry including Bayer CropScience (Germany), BASF (Germany), Monsanto (U.S.), and Dow AgroSciences (U.S.).

The global seed treatment market reached to over $2250.0 million by the end of year 2010, and is expected to reach $3430.3 million by 2016, growing at a CAGR of 13.5% from 2011 to 2016. The North American market is expected to hold 22% of the global market share by 2016, at an estimated CAGR of 16.4% due to higher acceptance of GM seeds for soybean and maize/corn. Asia-Pacific is another fastest growing segment due to the constant push by government bodies for adoption of seed treatments with “100% seed treatment campaign”. The market share of Asia-Pacific is expected to boost from $157.5 million in 2010 to $248.2 million by 2016, at an estimated CAGR of 14.4% from 2011 to 2016.

Seed treatment is the fastest growing segment in crop protection market. Seed treatments are further classified as insecticides (chemical), fungicides (chemical), bio-control seed treatments (non-chemical), and other seed treatment chemicals.

Seed Treatment Market

Published: January 2012
No. of Pages: 382
Price: Single User License – US$4650              Corporate User License – US$7150

                                   
Seed treatments are basically segmented further as chemical and non-chemical seed treatments. Bio-based seed treatments - a part of non-chemical seed treatments - are made up of renewable resources and contain natural active ingredients. These seed treatments do not have any negative impact on the environment, workers, and consumers safety comparing to chemical seed treatments and are expected to be one of the fastest growing seed treatment segments in the near future.

Chemical seed treatments, which are typically manufactured from petrochemical or inorganic raw materials, are further segmented as insecticides, fungicides, and other chemical seed treatments. Globally, the market is dominated by chemical insecticides, accounting for over 52% of the total seed treatment demand in 2010. The global fungicide seed treatments market is expected to reach $1,247.3 million by 2016, growing at a CAGR of 15.2%. The global insecticides seed treatment market is projected to reach $1,591.1 million by 2016, growing at a CAGR of 11.4%

Rising GM seeds prices and cost effectiveness of seed treatments over other crop protection methods are expected to drive the demand for seed treatment market in the near future. However, absence of centralized government regulation for treated seed and seed treatment active ingredient registration expected to hamper the global movement of seeds and ultimately the demand for seed treatments in the next five years.

One of the critical success factors (CSFs) in the market is the ability of a market participant to innovate complete protection solution against various biotic and abiotic stresses in single product. This battle of manufacturing grower-friendly, crop-friendly, and environment-friendly product innovation is going to be one of the key strategies market players are following in seed treatment industry in the next five years.

Explore Comprehensive list of Tables & Figures available in the report @ http://www.reportsnreports.com/reports/144659-seed-treatment-market-trends-and-global-forecasts-2011-2016-.html

Pulmonary Drug Delivery Systems: Technologies and Global Markets

• The global pulmonary drug delivery technologies market which was $19.6 billion in 2010 is expected to be around $22.5 billion by 2011. This global market is further projected to reach nearly $44 billion by 2016 at a compound annual growth rate (CAGR) of 14.3%.
• The market for metered dose inhalers (MDIs) was $12.5 billion in 2010 and will reach $14.4 billion by the end of 2011. BCC forecasts this market will grow to $29.8 billion by 2016 at a CAGR of 15.7%.
• The market for dry powder inhalers (DPIs) was $6.6 billion in 2010. This market is expected to increase to $7.5 billion in 2011 and reach $13.4 billion by 2016 at a CAGR of 12.3%.

Pulmonary Drug Delivery Technologies Market

Published: January 2012

No. of Pages: 207

Price: Single User License – US$4850              Corporate User License – US$8500

                                          

STUDY GOALS AND OBJECTIVES
This BCC market research report, Pulmonary Drug Delivery Systems: Technologies and Global Markets, provides a detailed overview and thorough analysis of the present and future global market for pulmonary drug delivery technologies.  This report analyzes in detail the pulmonary drug delivery technologies that are available and currently used and their markets.  This report includes products in this market and detailed analyses of the markets and competitive environments.  It also analyzes current and future market prospects.  The report provides a comprehensive review of emerging pulmonary drug delivery technologies, particularly with regard to inhaled drug delivery systems.  The analysis reviews technological developments, product innovations, and recent strategic industry activities of major players across different product categories.  It reviews their strengths and weaknesses, opportunities, and the threats facing various devices and drugs in this market space.  The report also reviews developments already on the market, major issues involved in the research and development (R&D) of more effective devices for drug delivery to the lungs, and new products in development.

REASONS FOR DOING THE STUDY
Pulmonary drug delivery has emerged as a more relevant alternative for delivering drugs.   Respiratory conditions such as asthma, chronic obstructive pulmonary, and emphysema disease are therapeutic areas of the pulmonary sector.  However, recent technological advancements have applied the application of pulmonary devices to the treatment of nonrespiratory conditions such diabetes and migraines.  Advancements in formulating technology are expected to push sales of dry powder inhalers, replacing metered-dose inhalers to a large extent.   Pulmonary delivery of drugs for the treatment of respiratory diseases stems from the fact that topical drug deposition to the infected lung gives a fast therapeutic effect and reduces side effects associated with key drugs.   There is a need to understand the trends in this market, currently available devices and their problems, and the latest developments for drug delivery to the lungs.

SCOPE AND FORMAT
The report reviews global markets for drug delivery technologies and new developments, and forecasts trends for use of current devices for drug delivery and for safety and toxicology through 2016.   The report presents important devices, technologies, and the latest developments, market share by device and disease type, current products on the market, market share by company or product, and statistical information for types of respiratory diseases prevalent worldwide, with special emphasis on the U.S. market.   The report also includes current issues and trends affecting the industry including costs, and factors influencing demand will be discussed.  The report covers products in development, new technologies, trends, alliances, patents, and mergers.  The report offers market data with respect to segments and geography.  It also provides market trends with respect to drivers, restraints, and opportunities.

Explore Tables of Contents available in the report @ http://www.reportsnreports.com/reports/140371-pulmonary-drug-delivery-systems-technologies-and-global-markets.html.

Global Markets for Baby Foods -- Focus on Emerging Markets

• The global market for baby foods was $27.1 billion in 2010. The market is expected to reach $28.2 billion in 2011 and rise at a compound annual growth rate (CAGR) of 4.5% reaching $35.2 billion by 2016.
• The emerging markets region was valued at $3.1 in 2010, a value expected to reach nearly $3.3 billion in 2011. The region is forecast to reach $4.6 billion by 2016, a CAGR of 6.8%.

STUDY OBJECTIVES
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for baby foods.  The key objective is to present a comprehensive analysis of the current baby food market and its future direction including categories such as infant formula and baby meals.

This report explores present and future strategies within the baby food market.  The current state of the market, the setbacks, the innovations, and the future needs of the market are discussed in detail in this report.  A general overview of baby food, its types, market needs, benefits, limitations, and regulatory aspects are discussed in the report.
A detailed analysis of the structure of the baby food industry has been conducted.  This includes different types of baby foods such as infant formula and baby meals, which are further broken down by their market share as belonging to the categories’ leading manufacturers, and/or suppliers.  Revenues for each of the baby food categories are broken down by the region, including the four major markets of U.S., Europe, Asia, and the Rest of the World (ROW).  Sales figures are estimated for the 5-year period from 2011 through 2016.

The significant patents and their allocation in each category of baby food are included in the report.  Company profiles of major companies in the baby food business, including infant formula and baby meal manufacturers and processors are also included.

Baby Food Market

Published: January 2012
No. of Pages: 138
Price: Single User License – US$3900              Corporate User License – US$6835

                                              

REASONS FOR DOING THIS STUDY
This study was conducted to provide vital and detailed information regarding the use of baby food.  This industry is primed for growth, as the demand for baby food products is increasing.  Due to an increase in the number of women in the workplace, in addition to growing parental concerns about nutrition and modern day time constraints, baby food instant solutions such as infant formula and baby meals have become even more significant in meeting the current nutritional demands of infants and toddlers globally.  A growing overall concern for infant/toddler health in addition to time constraints have enabled many new baby food companies to originate globally.  These companies are striving to meet the current and potential future demand of providing quality baby food products worldwide.

Acquisitions, mergers, and alliances by companies and global organizations are also covered in this report.  The study also discusses the new technologies/developments, manufacturer/supplier competition, as well as the changing environment of the market, due to the increasing demand for commercial baby foods.

Explore Tables of Contents available in the report Global Markets for Baby Foods -- Focus on Emerging Markets@ http://www.reportsnreports.com/reports/144567-global-markets-for-baby-foods-focus-on-emerging-markets.html.

Epidemiology: Migraine – Stable adult population under 50 years will result in stable migraine prevalence

Migraine mainly affects adults aged between 18 and 49 years. Datamonitor expects a relatively stable number of migraine cases through to 2020 in the seven major markets as a result of a stable adult population.

Migraine has a high burden, as it affects productive adults and requires long-term treatment. Stroke, epilepsy, sinus headache, and psychiatric disorders are the main co-morbidities associated with migraine.

Request a Sample for or Inquire before buying the report @ http://www.reportsnreports.com/reports/144337-epidemiology-migraine-stable-adult-population-under-50-years-will-result-in-stable-migraine-prevalence.html

In this analysis, Datamonitor estimates that there were a total of 67.3 million cases of migraine in 2010 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). Prevalence rates for migraine are expected to remain constant as it is primarily a hereditary condition that can also be affected by hormonal changes, stress, and depression.

Features and benefits
• Gain insight into market potential, including a robust 10-year epidemiology forecast of prevalent migraine cases.
• Understand the key epidemiologic risk factors associated with migraine.

Explore Tables of Contents available in the report Epidemiology: Migraine – Stable adult population under 50 years will result in stable migraine prevalence.

Consumer Trends in the Suncare Market in the UK , 2011

This report provides the results for the Suncare market in the UK from Canadean’s unique, highly detailed and proprietary study of consumers’ Consumer Packaged Goods (CPG) consumption habits, and forms part of an overall series covering all CPG product markets.

Its coverage includes, but is not limited to, consumption behaviours, the extent to which consumer trends influence their consumption and the value of the market these trends influence, brand and private label choices as well as retailer choices. Much of this information can also be analyzed by specific consumer group, providing hard and fast data on consumers and markets at the product category level.

Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/143496-consumer-trends-in-the-suncare-market-in-the-uk-2011.html
Scope
• Consumers’ uptake of products and the influence of consumer trends are fundamental causes of change in markets – and as such marketers need to know what these trends are and be able to quantify their influence in the market.
• This report provides highly detailed insight into exactly who the consumer is and how the latest consumer trends are changing the market by examining over 20 consumer trends and the share of sales across over 30 consumer groups.

Reasons To Buy
The data provided allows marketers to track consumer behaviour through to its actual value impact on a product market. Unique in the market, this provides readers with a highly detailed data analysis of the market allowing marketing tactics and strategy to be updated in line with the very latest consumer behaviours.

Explore Comprehensive list of more than 90 Tables & Figures available in the report Consumer Trends in the Suncare Market in the UK , 2011.